Amesite Inc. — fact timeline

Amesite Inc. issued 696,866 shares of common stock (or pre-funded warrants in lieu thereof), Series A-1 warrants to purchase up to 696,866 shares and Series A-2 warrants to purchas of common stock to investors for purchase price of $1.435 per share (or pre-funded warrant in lieu thereof) and accompanying warrants.

“the Company entered into definitive agreements with the investors for the purchase and sale of 696,866 shares of common stock (or pre-funded warrants in lieu thereof), Series A-1 warrants to purchase up to 696,866 shares of the Company’s common stock and Series A-2 warrants to purchase up to 696,866 shares of the Company’s common stock at a purchase price of $1.435 per share (or pre-funded warrant in lieu thereof) and accompanying warrants.”

Amesite Inc. issued 696,866 shares of its common stock of common stock to investor for purchase price of $1.435 per share.

“announced that it has entered into definitive agreements for the purchase and sale of 696,866 shares of its common stock, at a purchase price of $1.435 per share in a registered direct offering priced at-the-market under Nasdaq rules.”

Amesite Inc. entered into Registration Rights Agreement with certain institutional investors (effective 2026-04-27).

“the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with certain institutional investors”

Amesite Inc. entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D, its Chairman and CEO, and George Parmer, a member of its board of directors valued at aggregate gross proceeds from the Insider-Led Private Placement are expected to be approximately $60 (effective 2026-04-27).

“026, the Company entered into PIPE Purchase Agreements with certain of its officers and directors, including Dr. Ann Marie Sastry, Ph.D,”

Amesite Inc. entered into PIPE Purchase Agreement with certain institutional investors valued at aggregate gross proceeds from Registered Direct and Private Placement are expected to be approximate (effective 2026-04-27).

“the Company entered into a securities purchase agreement (the “PIPE Purchase Agreement” and together with the RD Purchase Agreement, the “Purchase Agreements”) with certain institutional investors”

Amesite Inc. entered into RD Purchase Agreement with certain institutional investors valued at aggregate gross proceeds from Registered Direct and Private Placement are expected to be approximate (effective 2026-04-27).

“On April 27, 2026, Amesite Inc. (the “Company”) entered into a securities purchase agreement (the “RD Purchase Agreement”) with certain institutional investors”

Amesite Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“October 28, 2025 Amesite Inc. (“Amesite” or “the Company”) received a deficiency letter (the “Nasdaq Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market (the “Stockholders’ Equity Requirement”), nor is it in compliance with either of the alternative listing standards, either a market value of listed securities of at least $35 mill”

Amesite Inc. engaged Novogradac & Company LLP as its auditor.

“On June 24, 2025, the Company appointed Novogradac & Company LLP (“Novogradac”) as the Company’s new independent registered public accounting firm effective as of June 24, 2025.”

Amesite Inc. dismissed Turner, Stone & Company, L.L.P. as its auditor.

“On June 24, 2025, Amesite Inc. (the “Company”) dismissed Turner, Stone & Company, L.L.P. (“Turner Stone”) as the Company’s independent registered public accounting firm.”

Amesite Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“November 26, 2024, Amesite Inc. (“Amesite” or “the Company”) received a deficiency letter (the “Nasdaq Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on the Nasdaq Capital Market (the “Stockholders’ Equity Requirement”), nor is it in compliance with either of the alternative listing standards, either a market value of listed securities of at least $35 mi”

Sherlyn W. Farrell departed as Chief Financial Officer at Amesite Inc..

“the Board determined not to renew the engagement of Sherlyn W. Farrell, who previously served as the Company’s Chief Financial Officer since December 15, 2022.”

Sarah Berman was appointed as Principal Financial and Accounting Officer at Amesite Inc..

“authorized and approved the appointment of Sarah Berman as Principal Financial and Accounting Officer of the Company effective December 15, 2024.”

Amesite Inc.: Amesite Inc. amended its bylaws on May 14, 2024 to change the quorum requirement for stockholder meetings to 33 1/3% of outstanding voting shares (effective 2024-05-14).

“On May 14, 2024, the board of directors of Amesite, Inc. (the "Company") adopted resolutions to amend the Company’s bylaws to provide that at each meeting of stockholders, except where otherwise provided by law, the presence in person, or by remote communication, if applicable, or represented by proxy of the holders of thirty-three and one-third percent of the outstanding shares of the Company’s voting stock shall constitute a quorum.”

Amesite Inc. shareholders approved Ratification of the appointment of Turner, Stone & Company, L.L.P. as the Company’s independent registered public accounting firm for the year ending June 30, 2024 at the 2024-01-18 meeting.

“Proposal 2 The proposal to ratify the appointment of Turner, Stone & Company, L.L.P. as the Company’s independent registered public accounting firm for the year ending June 30, 2024 was approved based on the following votes: For Against Abstentions 1,335,824 16,449 2,817”

Amesite Inc. shareholders approved Election of three Class III Directors at the 2024-01-18 meeting.

“At the Company’s Annual Meeting of Stockholders held on January 18, 2024, the stockholders considered and approved two proposals, each of which is described in more detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on December 8, 2023 for the Annual Meeting of Stockholders. The results detailed below represent the final voting results as certified by the Inspector of Elections: Proposal 1 The stockholders elected the following three Class III Directors to hold office for a full term of three years or until their successors are duly elected and qualified based on the following votes: Director For Withheld Broker Non-Votes Anthony M. Barkett 879,831 22,793 452,466 Gilbert S. Omenn, M.D., Ph.D. 879,774 22,850 452,466 George Parmer 891,371 11,253 452,466”

Amesite Inc. shareholders rejected Amend 2018 Equity Incentive Plan to increase shares available by 3,000,000 shares and increase incentive stock option limit by 3,000,000 shares at the 2023-02-15 meeting.

“The result of the votes were as follows: For Against Abstentions 8,996,917 1,846,353 16,497”

Amesite Inc. shareholders approved Reverse stock split at a ratio within 1:5 to 1:50 at the 2023-02-15 meeting.

“The result of the votes were as follows: For Against Abstentions 98,022,343 17,445,060 24,907”

Amesite Inc.: Amended certificate of incorporation to effect a 1-for-12 reverse stock split (effective 2023-02-21).

“On February 21, 2023, the Company filed with the Secretary of State of the State of Delaware a certificate of amendment to its certificate of incorporation (the “Certificate of Amendment”) to effect the Reverse Stock Split. The Reverse Stock Split became effective as of 4:01 p.m. Eastern Time on February 21, 2023”

Amesite Inc. engaged Turner, Stone & Company, L.L.P. as its auditor.

“On January 27, 2023, the Company appointed Turner, Stone & Company, L.L.P. (“Turner Stone”) as the Company’s new independent registered public accounting firm effective as of January 27, 2023.”

Amesite Inc. dismissed Deloitte & Touche LLP as its auditor.

“On January 27, 2023, Amesite Inc. (the “Company”) dismissed Deloitte & Touche LLP (“Deloitte”) as the Company’s independent registered public accounting firm.”

Amesite Inc.: Filed Certificate of Designation creating Series A Preferred Stock with voting rights and redemption provisions (effective 2023-01-23).

“On January 23, 2023, the Company filed a Certificate of Designation of the Series A Preferred Stock (the “Certificate of Designation”) with the Secretary of State of the State of Delaware to create a new class of Series A Preferred Stock, par value $0.0001 per share.”

Amesite Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm at the 2022-12-15 meeting.

“Proposal 2 The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending June 30, 2023 was approved based on the following votes: For Against Abstentions 16,197,834 78,572 63,904”

Amesite Inc. shareholders approved Election of two Class I Directors at the 2022-12-15 meeting.

“Proposal 1 The stockholders elected the following two Class I Directors to hold office until the 2024 Annual Meeting of Stockholders or until their successors are duly elected and qualified based on the following votes: Director For Withheld Broker Non-Votes Ann Marie Sastry, Ph.D. 12,314,140 487,830 3,538,340 Barbie Brewer 12,311,041 490,929 3,538,340”

Mark Corrao departed as Chief Financial Officer at Amesite Inc..

“the Board determined not to renew the engagement of Mark Corrao, who previously served as the Company’s Chief Financial Officer since December 15, 2021 for a term of one year in accordance with the CFO Agreement between the Company and Mr. Corrao.”

Sherlyn W. Farrell was appointed as Chief Financial Officer at Amesite Inc..

“On December 9, 2022, the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the appointment of Sherlyn W. Farrell, age 60, as Chief Financial Officer of the Company effective December 15, 2022.”

Mark Corrao was appointed as Chief Financial Officer at Amesite Inc..

“In addition, on December 15, 2021, in connection with the termination of Mr. Kern, the Board authorized and approved the appointment of Mark Corrao, age 64, as Chief Financial Officer of the Company.”

Matthew Kern was terminated as Chief Financial Officer at Amesite Inc..

“On December 15, 2021 (the “Effective Date”), the board of directors (the “Board”) of Amesite Inc. (the “Company”) authorized and approved the termination of Matthew Kern as Chief Financial Officer of the Company, effective as of the Effective Date.”